Bank of Montreal
ORMP icon

Bank of Montreal’s Oramed Pharmaceuticals ORMP Stock Holding History

Bank of Montreal’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,400
Closed -$12K – 4528
2019
Q4 		$12K Buy
+2,400
New +$8.99K ﹤0.01% 4521

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal's ORMP Position: Q3 2022 in Review

Bank of Montreal sold out of Oramed Pharmaceuticals (ORMP) in Q3 2022, closing a stake of 249,200 shares — an estimated $1.35K sold.

Bank of Montreal first reported a position in ORMP in Q4 2015 and held it in 22 quarters. The position peaked at $23K in Q4 2017. 71 funds tracked by Wall St. Rank hold ORMP as of Q3 2022.

  • Bank of Montreal reported no remaining Oramed Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 249,200 Oramed Pharmaceuticals shares in Q3 2022, an estimated $1.35K.
  • Bank of Montreal first reported a position in Oramed Pharmaceuticals in Q4 2015 and held it in 22 quarters.
  • Bank of Montreal's Oramed Pharmaceuticals position peaked at $23K in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.